| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1037726204 |
| P356 | DOI | 10.1007/S00213-013-3295-2 |
| P698 | PubMed publication ID | 24114428 |
| P2093 | author name string | R J Rodgers | |
| F L Wright | |||
| P2860 | cites work | Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies | Q24650977 |
| Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors | Q24681893 | ||
| A review of central 5-HT receptors and their function | Q28142963 | ||
| International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin) | Q28239487 | ||
| Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats | Q28249545 | ||
| 5-HT2C receptor activation decreases appetite and body weight in obese subjects | Q28253985 | ||
| Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists | Q28278816 | ||
| Serotonergic drugs : effects on appetite expression and use for the treatment of obesity | Q28282364 | ||
| Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors | Q28284027 | ||
| m-Chlorophenylpiperazine decreases food intake in a test meal | Q28307494 | ||
| 'Liking' and 'wanting' food rewards: brain substrates and roles in eating disorders | Q30489108 | ||
| Synergistic efects of opioid and cannabinoid antagonists on food intake | Q32014540 | ||
| SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats | Q33942180 | ||
| The tempted brain eats: pleasure and desire circuits in obesity and eating disorders | Q34032576 | ||
| New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier? | Q34129885 | ||
| Dose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primates | Q34150227 | ||
| Mechanisms underlying current and future anti-obesity drugs | Q34322175 | ||
| Central serotonin and melanocortin pathways regulating energy homeostasis | Q35173358 | ||
| The utility of animal models to evaluate novel anti-obesity agents | Q35589958 | ||
| Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study | Q35677262 | ||
| Endogenous opioids and feeding behavior: a 30-year historical perspective | Q35785708 | ||
| The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control | Q35837700 | ||
| Inhibition of opioid transmission at the μ-opioid receptor prevents both food seeking and binge-like eating | Q36323534 | ||
| Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy | Q37368085 | ||
| From taste hedonics to motivational drive: central μ-opioid receptors and binge-eating behaviour | Q37477414 | ||
| Contrave, a bupropion and naltrexone combination therapy for the potential treatment of obesity | Q37602626 | ||
| "Weighing in" on synergy: preclinical research on neurohormonal anti-obesity combinations | Q37680204 | ||
| Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite | Q37705616 | ||
| Pharmacological management of appetite expression in obesity | Q37710372 | ||
| CNS regulation of appetite | Q37982153 | ||
| What is the prognosis for new centrally-acting anti-obesity drugs? | Q37982154 | ||
| Animal models to explore the effects of CNS drugs on food intake and energy expenditure | Q38019751 | ||
| Anti-obesity drugs: past, present and future | Q38036925 | ||
| Effects of naltrexone on food preference and concurrent behavioral responses in food-deprived rats | Q39222042 | ||
| Night and day: diurnal differences in the behavioural satiety sequence in male rats | Q39981929 | ||
| Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry | Q40093729 | ||
| Multiple serotonin receptors: opportunities for new treatments for obesity? | Q41026153 | ||
| Effects of naloxone and naltrexone on meal patterns of freely-feeding rats | Q41456198 | ||
| Sibutramine & naloxone: infra-additive interaction in the regulation of appetite? | Q43264198 | ||
| Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats | Q43688883 | ||
| A new glucagon and GLP-1 co-agonist eliminates obesity in rodents | Q43756107 | ||
| Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats | Q43858350 | ||
| Serotonin 2C receptor agonists and the behavioural satiety sequence in mice. | Q43913101 | ||
| Effect of opioid and cannabinoid receptor antagonism on orphanin FQ-induced hyperphagia in rats | Q44028213 | ||
| Activation of central melanocortin pathways by fenfluramine | Q44079737 | ||
| Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo | Q44222626 | ||
| Interaction between opioid agonists or naloxone and 5-HTP on feeding behavior in food-deprived rats | Q44349012 | ||
| Palatability, food intake and the behavioural satiety sequence in male rats | Q44624775 | ||
| Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats | Q44826752 | ||
| Reduced hypophagic effects of d-fenfluramine and the 5-HT2C receptor agonist mCPP in 5-HT1B receptor knockout mice | Q44892908 | ||
| Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles | Q46240693 | ||
| Rational design of a combination medication for the treatment of obesity | Q46255375 | ||
| Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats | Q46405494 | ||
| Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice | Q46525214 | ||
| Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats | Q46535152 | ||
| Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching | Q46659888 | ||
| Effects of a Cannabinoid1 receptor antagonist and Serotonin2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice | Q46767789 | ||
| Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study. | Q47270495 | ||
| Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity | Q47272388 | ||
| Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study | Q47321369 | ||
| Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat. | Q47342941 | ||
| Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats | Q47427740 | ||
| 5-HT(2C) receptor activation inhibits appetitive and consummatory components of feeding and increases brain c-fos immunoreactivity in mice. | Q48140056 | ||
| Combined injection potentiates the satiety effects of pancreatic glucagon, cholecystokinin, and bombesin. | Q48278684 | ||
| Effects of food deprivation and mCPP treatment on the microstructure of ingestive behaviour of male and female rats | Q48348417 | ||
| Brainstem sensing of meal-related signals in energy homeostasis | Q48575606 | ||
| Combined naloxone and fluoxetine on deprivation-induced binge eating of palatable foods in rats | Q48734137 | ||
| Effect of hypothalamic and peripheral fluoxetine injection on natural patterns of macronutrient intake in the rat | Q48805783 | ||
| Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists | Q48848141 | ||
| m-Chlorophenylpiperazine enhances neophobic and anxious behaviour in mice | Q48862784 | ||
| Naloxone and serotonin receptor subtype antagonists: interactive effects upon deprivation-induced intake | Q48874896 | ||
| Dual action of naloxone on feeding revealed by behavioural analysis: separate effects on initiation and termination of eating | Q49022242 | ||
| Effects of RO 60 0175, a 5-HT(2C) receptor agonist, in three animal models of anxiety. | Q51083229 | ||
| Effects of systematic variation in presatiation and fasting on the behavioural satiety sequence in male rats. | Q51535635 | ||
| Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake. | Q52531846 | ||
| Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash. | Q52638749 | ||
| Behaviourally-selective hypophagic effects of naloxone in non-deprived male rats presented with palatable food. | Q52852561 | ||
| Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP. | Q52873443 | ||
| Effect of naloxone and naltrexone on the development of satiation measured in the runway: comparisons with d-amphetamine and d-fenfluramine. | Q52943295 | ||
| The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze. | Q54102296 | ||
| Combination pharmaceutical therapies for obesity | Q57314317 | ||
| Serotonin Reciprocally Regulates Melanocortin Neurons to Modulate Food Intake | Q57912931 | ||
| Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist, and d-fenfluramine on feeding patterns in the rat | Q60054744 | ||
| An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats | Q60054753 | ||
| 5-HT1B agonists induce anorexia at a postsynaptic site | Q60054778 | ||
| Paraventricular nucleus controls 5-HT2C receptor-mediated corticosterone and prolactin but not oxytocin and penile erection responses | Q60710700 | ||
| Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations | Q60710714 | ||
| Synergy between amylin and cholecystokinin for inhibition of food intake in mice | Q77372246 | ||
| Interactions between leptin and exendin-4, a glucagon-like peptide-1 agonist, in the regulation of food intake in the rat | Q80593655 | ||
| P433 | issue | 4 | |
| P921 | main subject | naltrexone | Q409587 |
| P1104 | number of pages | 14 | |
| P304 | page(s) | 787-800 | |
| P577 | publication date | 2013-10-11 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination | |
| P478 | volume | 231 |
| Q27347643 | Attention bias to threat indicates anxiety differences in sheep. |
| Q51744991 | Behavioural profile of exendin-4/naltrexone dose combinations in male rats during tests of palatable food consumption. |
| Q93093150 | Effects of early and later life environmental enrichment and personality on attention bias in pigs (Sus scrofa domesticus) |
| Q36402156 | Evaluating pharmacological models of high and low anxiety in sheep |
| Q47738255 | Evidence for a role of 5-HT2C receptors in the motor aspects of performance, but not the efficacy of food reinforcers, in a progressive ratio schedule. |
| Q39059417 | Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats |
| Q47223800 | Towards a more practical attention bias test to assess affective state in sheep. |
Search more.